Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia to VSV-induced oncolysis

被引：0
|
作者：
Tumilasci, Vanessa F. [1 ,3 ]
Oliere, Stephanie [1 ,3 ]
Bell, John [2 ]
Hiscott, John [1 ,3 ]
机构：
[1] McGill Univ, Mol Oncol Grp, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Ottawa, ON, Canada
来源：
CYTOKINE | 2008年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.cyto.2008.07.262
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [1] Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis
    Tumilasci, Vanessa Fonseca
    Oliere, Stephanie
    Nguyen, Thi Lien-Ahn
    Shamy, April
    Bell, John
    Hiscott, John
    JOURNAL OF VIROLOGY, 2008, 82 (17) : 8487 - 8499
  • [2] BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis
    Samuel, Sara
    Beljanski, Vladimir
    Van Grevenynghe, Julien
    Richards, Stephanie
    Ben Yebdri, Fethia
    He, Zhong
    Nichols, Carmen
    Belgnaoui, S. Mehdi
    Steel, Courtney
    Goulet, Marie-Line
    Shamy, April
    Brown, Dawn
    Abesada, Guillermo
    Haddad, Elias K.
    Hiscott, John
    MOLECULAR THERAPY, 2013, 21 (07) : 1413 - 1423
  • [3] VSV Oncolysis in Combination With the BCL-2 Inhibitor Obatoclax Overcomes Apoptosis Resistance in Chronic Lymphocytic Leukemia
    Samuel, Sara
    Tumilasci, Vanessa F.
    Oliere, Stephanie
    Nguyen, Thi Lien-Anh
    Shamy, April
    Bell, John
    Hiscott, John
    MOLECULAR THERAPY, 2010, 18 (12) : 2094 - 2103
  • [4] Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia
    Goolsby, C
    Paniagua, M
    Tallman, M
    Gartenhaus, RB
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 63B (01) : 36 - 46
  • [5] Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells
    Campas, Clara
    Cosialls, Ana M.
    Barragan, Montserrat
    Iglesias-Serret, Daniel
    Santidrian, Antonio F.
    Coll-Mulet, Llorenc
    de Frias, Merce
    Domingo, Alicia
    Pons, Gabriel
    Gil, Joan
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (12) : 1663 - 1669
  • [6] Bcl-2 and apoptosis in chronic lymphocytic leukemia
    Aaron D. Schimmer
    Irene Munk-Pedersen
    Mark D. Minden
    John C. Reed
    Current Treatment Options in Oncology, 2003, 4 (3) : 211 - 218
  • [7] The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Benjamin L. Lampson
    Matthew S. Davids
    Current Hematologic Malignancy Reports, 2017, 12 : 11 - 19
  • [8] The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Davids, Matthew S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 11 - 19
  • [9] bcl-2 blocks VSV-induced apoptosis upstream of caspase-3 activation without hindering VSV replication.
    Hobbs, J
    Hommel-Berrey, G
    N'cho, M
    Brahmi, Z
    FASEB JOURNAL, 1998, 12 (05): : A1070 - A1070
  • [10] BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
    Perini, Guilherme Fleury
    Pellegrino Feres, Carolina Cristina
    Cardoso Teixeira, Larissa Lane
    Hamerschlak, Nelson
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (08)
12345